1D·

Partnership Hims&Hers and Novo Nordisk 😎

$HIMS (-6.72%) and $NOVO B (+1.38%) have announced a groundbreaking collaboration to make obesity treatment more accessible and affordable in America.

The partnership's first initiative introduces Wegovy through the $HIMS (-6.72%) -platform, bundled with comprehensive healthcare services for $599 per month.

The offer combines all of Wegovy's dosage strengths with the benefits of a $HIMS (-6.72%) -membership, including:

- 24/7 care access

- Ongoing clinical support

- Nutritional counseling

- Access to the NovoCare pharmacy

VERY positive for $HIMS (-6.72%) as it all but negates the entire pessimistic assessment of potential lawsuits.

🚀

BamBamInvest

@BamBamInvest

1D·

Hims Partners with Novo Nordisk 🚀

$HIMS (-6.72%)

There is no other way, it has to be Mr. again 😂

11 Comments

~ S.@Semos25

$HIMS to the Moon

•

AdriInvests@AdriInvests

Läuft 🤝

•

BamBamInvest@BamBamInvest

@AdriInvests I am curious what will happen when US opens with 30% short odds. Let's see if we can hold that 😎

••

AdriInvests@AdriInvests

@BamBamInvest would almost think it could trigger another short squeeze if the orders are executed right away. Let's see. I'm just surprised that $LFMD is also up 26% pre-market 😂

•

AdriInvests@AdriInvests

Ok, I read on X that $LFMD will also offer wegovy. Even another $100 cheaper than $HIMS 🧐

•

BamBamInvest@BamBamInvest

@AdriInvests Let's see, with a short rate of 33%, some will certainly buy up again over the next few weeks.

•

BamBamInvest@BamBamInvest

@AdriInvests yes, but it's not just wegovy but the whole package and $HIMS has a much larger market share here

•

Colonia@colonia_official

And the short sellers are knocked out once again

•

Shem_sen@Shem_sen

@colonia_official went long immediately after this news 😇🚀

•

userc811746a6d9041b6@userc811746a6d9041b6

Why shouldn't customers just go directly through NovoCare and buy the weight loss injection for $499. I don't know if the services are that popular there.

••

BamBamInvest@BamBamInvest

@userc811746a6d9041b6 Take a look at the growth of $HIMS, even before GLP 1 came along. Look at the cost of a doctor's visit in the US, where there are no great social benefits. Health insurance companies also have high deductibles, cheap doctor visits are increasingly sought after and in my opinion $HIMS also benefits when consumers are worse off. Cross-selling with existing products that you already consume is also a point, you have a doctor's consultation and the doctor prescribes you something and you take out a subscription or buy it via $HIMS, why should they go anywhere else? The more you look into the healthcare system in a capitalist America, the more you will realize that $HIMS will benefit in my opinion. ✌️

•